CoRegen Inc. logo — company profile

CoRegen Inc.

Founded 2019 2 employees Venture round Biotechnology

General Information

Company Name CoRegen Inc.
Founded Year 2019
Employees 2
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with CoRegen Inc.. To contact CoRegen Inc., visit coregeninc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CoRegen Inc. compare?

A PDF of CoRegen Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CoRegen Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CoRegen Inc.

CoRegen Inc. is a biotechnology startup founded in 2019 that is making waves with its groundbreaking master gene regulator platform. The company is focused on developing a diverse range of therapeutics capable of controlling numerous genes throughout the body, with a primary focus on lead indications in solid tumors. CoRegen's innovative approach holds potential for significant impact in the field of biotechnology, particularly in the realm of gene therapy and precision medicine. As of now, specific details regarding the headquarter location, recent slogans, or past investment rounds for CoRegen are not publicly available, leaving the company's current financial and operational status a bit of a mystery for outside observers. Given the promising nature of its technology and the potential applications in addressing various medical conditions, CoRegen's progress and any future funding activities could attract interest from venture capital firms and investors focused on the biotechnology sector.

No funding data available for CoRegen Inc. yet.

CoRegen Inc. Alternatives & Competitors

View All Alternatives
CoRegen Inc. vs

Delivering a cancer-free future

Post-IPO Equity
11 employees
Biotechnology, Health Care
CoRegen Inc. vs

We seek to address the significant unmet need for safe and efficient treatments for chronic pain-rel...

Series C
9 employees
Biotechnology, Health Care
CoRegen Inc. vs

Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developi...

Series D
10 employees
Biotechnology, Health and Wellness

FAQ About CoRegen Inc.

CoRegen is leveraging its groundbreaking master gene regulator platform to develop a broad range of therapeutics capable of controlling numerous genes throughout the body, with lead indications in solid tumors.
CoRegen Inc. was founded in 2019.
CoRegen Inc. operates in Biotechnology.
CoRegen Inc. has approximately 2 employees.
Top alternatives and competitors to CoRegen Inc. include TransCode Therapeutics, Inc., Xalud Therapeutics, Inc., Decibel Therapeutics, Resalis Therapeutics, Avenge Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CoRegen Inc. and TransCode Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CoRegen Inc., https://bouncewatch.com/company/coregen-inc, updated 3 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes